|Articles|September 15, 2002

Ophthalmologists can tackle dry eye with a variety of plugs

The many forms and causes of dry eye syndrome are targeted by a nearly equal number of devices to treat the malady.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Related Content

Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data

ByLucia Gambuzza

July 30th 2026

Emerging dry eye therapies and co-managing MGD: Ping Moore, OD

ByYun Ping Moore, OD,Lucia Gambuzza

Published: July 23rd 2026 | Updated: July 23rd 2026

Why aren’t there enough ophthalmologists?

ByPeter J. McDonnell, MD

July 20th 2026

Personalizing dry eye treatment by addressing disease at its source

ByMarjan Farid, MD

July 17th 2026

Q&A with Esen Akpek, MD | Ophthalmology Times

Root cause–based dry eye classification and the shift toward precision medicine

ByLucia Gambuzza,Esen K. Akpek, MD

July 15th 2026

Latest CME

Video

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Video

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Ophthalmologists can tackle dry eye with a variety of plugs

Related Content

Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data

Emerging dry eye therapies and co-managing MGD: Ping Moore, OD

Why aren’t there enough ophthalmologists?

Personalizing dry eye treatment by addressing disease at its source

Root cause–based dry eye classification and the shift toward precision medicine

Latest CME

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Trending on Eye Care Network - Ophthalmology Times

FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance

Linsitinib phase 3 ORBIT trial doses first patients for thyroid eye disease

The association between atrial fibrillation and the eye

RCA releases first State of Retina Care report

OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news